Mesoblast price target raised to $39 from $35 at Piper Sandler
Upside catalyst from analyst target upgrade.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside catalyst from analyst target upgrade.
What happened, with direct paths to the underlying reporting
Piper Sandler raises MESO target to $39; current price $16.84.
Target: $39
Posted price: $16.84
Analyst firm: Piper Sandler
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.